Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aprea Therapeutics Inc

APRE
Current price
5.19 USD +0.19 USD (+3.80%)
Last closed 5.3 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 28 182 842 USD
Yield for 12 month +36.58 %
1Y
3Y
5Y
10Y
15Y
APRE
21.11.2021 - 28.11.2021

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania. Address: 3805 Old Easton Road, Doylestown, PA, United States, 18902

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.67 USD

P/E ratio

Dividend Yield

Current Year

+583 231 USD

Last Year

Current Quarter

+380 569 USD

Last Quarter

+14 075 USD

Current Year

+576 178 USD

Last Year

-186 445 USD

Current Quarter

+374 411 USD

Last Quarter

+9 089 USD

Key Figures APRE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -15 464 911 USD
Operating Margin TTM -26109.62 %
PE Ratio
Return On Assets TTM -36.63 %
PEG Ratio
Return On Equity TTM -63.19 %
Wall Street Target Price 15.67 USD
Revenue TTM 583 231 USD
Book Value 4.54 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.28 USD
Diluted Eps TTM -3.28 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics APRE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History APRE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 13.02.2023
Dividend Date

Stock Valuation APRE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 49.3368
Enterprise Value EBITDA 0.3457
Price Book MRQ 0.9948

Financials APRE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators APRE

For 52 weeks

2.78 USD 8.85 USD
50 Day MA 5.74 USD
Shares Short Prior Month 90 660
200 Day MA 5 USD
Short Ratio 12.2
Shares Short 32 354
Short Percent 2.25 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds


S

SX7EEX

14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics